Lagget M - Search Results

1

Four years of treatment with lamivudine: clinical and virological evaluations in HBe antigen-negative chronic hepatitis B.

Gaia S, Marzano A, Smedile A, Barbon V, Abate ML, Olivero A, Lagget M, Paganin S, Fadda M, Niro G, Rizzetto M. Gaia S, et al. Among authors: lagget m. Aliment Pharmacol Ther. 2004 Aug 1;20(3):281-7. doi: 10.1111/j.1365-2036.2004.02073.x. Aliment Pharmacol Ther. 2004. PMID: 15274664 Free article.

2

Treatment of hepatitis B e antigen-negative chronic hepatitis B with lamivudine.

Rizzetto M, Marzano A, Lagget M. Rizzetto M, et al. Among authors: lagget m. J Hepatol. 2003;39 Suppl 1:S168-71. doi: 10.1016/s0168-8278(03)00311-8. J Hepatol. 2003. PMID: 14708698 Review. No abstract available.

3

Lamivudine-resistant chronic hepatitis B: an observational study on adefovir in monotherapy or in combination with lamivudine.

Gaia S, Barbon V, Smedile A, Olivero A, Carenzi S, Lagget M, Alessandria C, Rizzetto M, Marzano A. Gaia S, et al. Among authors: lagget m. J Hepatol. 2008 Apr;48(4):540-7. doi: 10.1016/j.jhep.2007.12.018. Epub 2008 Jan 31. J Hepatol. 2008. PMID: 18279995

4

Treatment of chronic hepatitis B.

Lagget M, Rizzetto M. Lagget M, et al. Curr Pharm Des. 2002;8(11):953-8. doi: 10.2174/1381612024607054. Curr Pharm Des. 2002. PMID: 11945141 Review.

5

Current pharmacotherapy for the treatment of chronic hepatitis B.

Lagget M, Rizzetto M. Lagget M, et al. Expert Opin Pharmacother. 2003 Oct;4(10):1821-7. doi: 10.1517/14656566.4.10.1821. Expert Opin Pharmacother. 2003. PMID: 14521491 Review.

6

Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study.

Niro GA, Ciancio A, Tillman HL, Lagget M, Olivero A, Perri F, Fontana R, Little N, Campbell F, Smedile A, Manns MP, Andriulli A, Rizzetto M. Niro GA, et al. Among authors: lagget m. Aliment Pharmacol Ther. 2005 Aug 1;22(3):227-32. doi: 10.1111/j.1365-2036.2005.02542.x. Aliment Pharmacol Ther. 2005. PMID: 16091060 Free article. Clinical Trial.

7

Prompt relapse of viremia after lamivudine discontinuation in e-minus chronic hepatitis B patients completely responders during 5 years of therapy.

Barbon V, Gaia S, Marzano A, Lagget M, Rizzetto M. Barbon V, et al. Among authors: lagget m. J Hepatol. 2004 Sep;41(3):500-1. doi: 10.1016/j.jhep.2004.04.018. J Hepatol. 2004. PMID: 15336458 No abstract available.

8

Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B.

Rizzetto M, Tassopoulos NC, Goldin RD, Esteban R, Santantonio T, Heathcote EJ, Lagget M, Taak NK, Woessner MA, Gardner SD. Rizzetto M, et al. Among authors: lagget m. J Hepatol. 2005 Feb;42(2):173-9. doi: 10.1016/j.jhep.2004.10.006. J Hepatol. 2005. PMID: 15664241 Clinical Trial.

9

Hepatitis type C after orthotopic liver transplantation: reinfection and disease recurrence.

Marzano A, Smedile A, Abate M, Ottobrelli A, Brunetto M, Negro F, Farci P, Durazzo M, David E, Lagget M, et al. Marzano A, et al. Among authors: lagget m. J Hepatol. 1994 Dec;21(6):961-5. doi: 10.1016/s0168-8278(05)80602-6. J Hepatol. 1994. PMID: 7699259

10

Hepatitis B: therapeutic perspectives.

Rizzetto M, Lagget M. Rizzetto M, et al. Among authors: lagget m. Forum (Genova). 2001 Apr-Jun;11(2):137-50. Forum (Genova). 2001. PMID: 11948359 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters